FHTX · Company research

Foghorn Therapeutics Inc. (FHTX): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 20262.09$248,615,554.88180535554.88———15.4688622996515679——

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.